Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Aug;89(8):757–762. doi: 10.1136/adc.2003.036921

Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation

P Ispahani 1, R Slack 1, F Donald 1, V Weston 1, N Rutter 1
PMCID: PMC1720039  PMID: 15269078

Abstract

Aims: To evaluate the incidence, spectrum of clinical manifestations, and outcome of invasive pneumococcal disease (IPD) in children. To determine the major serogroups of Streptococcus pneumoniae responsible for invasive disease and the potential coverage by the new pneumococcal conjugate vaccines.

Methods: Analysis of prospectively recorded information of all children admitted to two teaching hospitals in Nottingham with IPD between January 1980 and December 1999.

Results: A total of 266 episodes of IPD in children were identified; 103 (39%) were aged <1 year and 160 (60%) <2 years. Major clinical presentations were meningitis in 86 (32%), pneumonia in 82 (31%), and bacteraemia without an obvious focus in 80 (30%). The age specific mean annual incidence rates of IPD overall among children aged <1, <2, and <5 years were 47.1, 37.8, and 20 per 100 000 population, respectively. Mortality rates for children with meningitis and non-meningitic infection were 20% and 7%, respectively. Neurological sequelae following meningitis were documented in 16 (26%) of the 61 survivors assessed. The potential coverage rates in children between the ages of 6 months and 5 years are 84% by the 7-valent, 91% by the 9-valent, and 95% by the 11-valent conjugate vaccines.

Conclusion: This study indicates that inclusion of a pneumococcal conjugate vaccine in the primary immunisation programme in the UK would have a considerable effect on the mortality and morbidity associated with IPD.

Full Text

The Full Text of this article is available as a PDF (201.0 KB).

Figure 1.

Figure 1

Open in a new tab

 A total of 266 episodes of invasive pneumococcal disease by age.

Figure 2.

Figure 2

Open in a new tab

 Coverage rates by pneumococcal conjugate vaccines (PCV) against invasive pneumococcal disease in children of different age groups.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. G., Deaver K. A., Cochi S. L., Plikaytis B. D., Zell E. R., Broome C. V., Wenger J. D. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993 Jan 13;269(2):221–226. [PubMed] [Google Scholar]
  2. Appelbaum Peter C. Resistance among Streptococcus pneumoniae: Implications for drug selection. Clin Infect Dis. 2002 May 16;34(12):1613–1620. doi: 10.1086/340400. [DOI] [PubMed] [Google Scholar]
  3. Arditi M., Mason E. O., Jr, Bradley J. S., Tan T. Q., Barson W. J., Schutze G. E., Wald E. R., Givner L. B., Kim K. S., Yogev R. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998 Nov;102(5):1087–1097. doi: 10.1542/peds.102.5.1087. [DOI] [PubMed] [Google Scholar]
  4. Baraff L. J., Lee S. I., Schriger D. L. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993 May;12(5):389–394. doi: 10.1097/00006454-199305000-00008. [DOI] [PubMed] [Google Scholar]
  5. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J. R., Elvin L., Ensor K. M., Hackell J., Siber G. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar;19(3):187–195. doi: 10.1097/00006454-200003000-00003. [DOI] [PubMed] [Google Scholar]
  6. Bradley J. S., Kaplan S. L., Klugman K. P., Leggiadro R. J. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995 Dec;14(12):1037–1041. [PubMed] [Google Scholar]
  7. Breiman R. F., Spika J. S., Navarro V. J., Darden P. M., Darby C. P. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. Arch Intern Med. 1990 Jul;150(7):1401–1405. [PubMed] [Google Scholar]
  8. Burman L. A., Norrby R., Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis. 1985 Mar-Apr;7(2):133–142. doi: 10.1093/clinids/7.2.133. [DOI] [PubMed] [Google Scholar]
  9. Colman G., Cooke E. M., Cookson B. D., Cooper P. G., Efstratiou A., George R. C. Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol. 1998 Jan;47(1):17–27. doi: 10.1099/00222615-47-1-17. [DOI] [PubMed] [Google Scholar]
  10. Dagan R., Engelhard D., Piccard E., Englehard D [corrected to Engelhard D. ]. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA. 1992 Dec 16;268(23):3328–3332. [PubMed] [Google Scholar]
  11. Davis C. W., McIntyre P. B. Invasive pneumococcal infection in children, 1981-92: a hospital-based study. J Paediatr Child Health. 1995 Aug;31(4):317–322. doi: 10.1111/j.1440-1754.1995.tb00819.x. [DOI] [PubMed] [Google Scholar]
  12. Eskola J., Anttila M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J. 1999 Jun;18(6):543–551. doi: 10.1097/00006454-199906000-00015. [DOI] [PubMed] [Google Scholar]
  13. Eskola J., Takala A. K., Kela E., Pekkanen E., Kalliokoski R., Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1992 Dec 16;268(23):3323–3327. [PubMed] [Google Scholar]
  14. Fraser D., Givon-Lavi N., Bilenko N., Dagan R. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 2001 Jul 11;33(4):421–427. doi: 10.1086/321874. [DOI] [PubMed] [Google Scholar]
  15. Gomez M., Alter S., Kumar M. L., Murphy S., Rathore M. H. Neonatal Streptococcus pneumoniae infection: case reports and review of the literature. Pediatr Infect Dis J. 1999 Nov;18(11):1014–1018. doi: 10.1097/00006454-199911000-00016. [DOI] [PubMed] [Google Scholar]
  16. Hargreaves R. M., Slack M. P., Howard A. J., Anderson E., Ramsay M. E. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ. 1996 Jan 20;312(7024):160–161. doi: 10.1136/bmj.312.7024.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hausdorff W. P., Bryant J., Kloek C., Paradiso P. R., Siber G. R. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 2000 Jan;30(1):122–140. doi: 10.1086/313609. [DOI] [PubMed] [Google Scholar]
  18. Hausdorff W. P., Bryant J., Paradiso P. R., Siber G. R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000 Jan;30(1):100–121. doi: 10.1086/313608. [DOI] [PubMed] [Google Scholar]
  19. Ispahani P., Pearson N. J., Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med. 1987 May;63(241):427–440. [PubMed] [Google Scholar]
  20. Ispahani P., Weston V. C., Turner D. P., Donald F. E. Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985-1998. Clin Infect Dis. 1999 Dec;29(6):1450–1454. doi: 10.1086/313526. [DOI] [PubMed] [Google Scholar]
  21. Jadavji T., Biggar W. D., Gold R., Prober C. G. Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics. 1986 Jul;78(1):21–25. [PubMed] [Google Scholar]
  22. Kaltoft, Zeuthen N., Konradsen H. B. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl. 2000 Dec;89(435):3–10. doi: 10.1111/j.1651-2227.2000.tb00775.x. [DOI] [PubMed] [Google Scholar]
  23. Kaplan Sheldon L., Mason Edward O., Jr, Wald EllenR, Tan Tina Q., Schutze Gordon E., Bradley John S., Givner Laurence B., Kim Kwang Sik, Yogev Ram, Barson William J. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002 Feb;21(2):141–147. doi: 10.1097/00006454-200202000-00011. [DOI] [PubMed] [Google Scholar]
  24. Klugman K. P. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990 Apr;3(2):171–196. doi: 10.1128/cmr.3.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kornelisse R. F., Westerbeek C. M., Spoor A. B., van der Heijde B., Spanjaard L., Neijens H. J., de Groot R. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis. 1995 Dec;21(6):1390–1397. doi: 10.1093/clinids/21.6.1390. [DOI] [PubMed] [Google Scholar]
  26. Kyaw M. H., Clarke S., Jones I. G., Campbell H. Incidence of invasive pneumococcal disease in Scotland, 1988-99. Epidemiol Infect. 2002 Apr;128(2):139–147. [PMC free article] [PubMed] [Google Scholar]
  27. Laurichesse H., Grimaud O., Waight P., Johnson A. P., George R. C., Miller E. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health. 1998 Mar;1(1):22–27. [PubMed] [Google Scholar]
  28. Miller E., Waight P., Efstratiou A., Brisson M., Johnson A., George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl. 2000 Dec;89(435):11–16. doi: 10.1111/j.1651-2227.2000.tb00776.x. [DOI] [PubMed] [Google Scholar]
  29. Pomeroy S. L., Holmes S. J., Dodge P. R., Feigin R. D. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med. 1990 Dec 13;323(24):1651–1657. doi: 10.1056/NEJM199012133232402. [DOI] [PubMed] [Google Scholar]
  30. Schuchat A., Robinson K., Wenger J. D., Harrison L. H., Farley M., Reingold A. L., Lefkowitz L., Perkins B. A. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997 Oct 2;337(14):970–976. doi: 10.1056/NEJM199710023371404. [DOI] [PubMed] [Google Scholar]
  31. Shackley F., Knox K., Morris J. B., Crook D., Griffiths D., Mayon-White R., George R., Willocks L., Moxon E. Outcome of invasive pneumococcal disease: a UK based study. Oxford Pneumococcal Surveillance Group. Arch Dis Child. 2000 Sep;83(3):231–233. doi: 10.1136/adc.83.3.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sleeman K., Knox K., George R., Miller E., Waight P., Griffiths D., Efstratiou A., Broughton K., Mayon-White R. T., Moxon E. R. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis. 2000 Dec 21;183(2):239–246. doi: 10.1086/317924. [DOI] [PubMed] [Google Scholar]
  33. Whitney Cynthia G., Pickering Larry K. The potential of pneumococcal conjugate vaccines for children. Pediatr Infect Dis J. 2002 Oct;21(10):961–970. doi: 10.1097/00006454-200210000-00016. [DOI] [PubMed] [Google Scholar]
  34. Zangwill K. M., Vadheim C. M., Vannier A. M., Hemenway L. S., Greenberg D. P., Ward J. I. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis. 1996 Oct;174(4):752–759. doi: 10.1093/infdis/174.4.752. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES